SAW
DGX icon

Signal Advisors Wealth’s Quest Diagnostics DGX Stock Holding History

Signal Advisors Wealth’s Portfolio DGX Stock Details DGX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q2 		– Sell
-2,620
Closed -$443K – 486
2025
Q1 		$443K Sell
2,620
-4
-0.2% -$657 0.04% 297
2024
Q4 		$396K Buy
2,624
+139
+6% +$21.6K 0.04% 301
2024
Q3 		$386K Buy
+2,485
New +$371K 0.06% 293

Other funds holding DGX

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Boston Partners
Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Victory Capital Management
Victory Capital Management San Antonio, Texas $156B AUM 27.51% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Signal Advisors Wealth's DGX Position: Q2 2025 in Review

Signal Advisors Wealth sold out of Quest Diagnostics (DGX) in Q2 2025, closing a stake of 2,620 shares — an estimated $443K sold.

Signal Advisors Wealth first reported a position in DGX in Q3 2024 and held it in 3 quarters. The position peaked at $443K in Q1 2025. 990 funds tracked by Wall St. Rank hold DGX as of Q2 2025.

  • Signal Advisors Wealth reported no remaining Quest Diagnostics position as of Q2 2025 after selling out during the quarter.
  • Signal Advisors Wealth sold 2,620 Quest Diagnostics shares in Q2 2025, an estimated $443K.
  • Signal Advisors Wealth first reported a position in Quest Diagnostics in Q3 2024 and held it in 3 quarters.
  • Signal Advisors Wealth's Quest Diagnostics position peaked at $443K in Q1 2025.
  • 990 funds tracked by Wall St. Rank held Quest Diagnostics as of Q2 2025.

Based on Signal Advisors Wealth's 13F filing for Q2 2025, filed 10 Jul 2025.